SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067204
Filing Date
2017-11-09
Accepted
2017-11-09 08:57:11
Documents
84
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20600_110q.htm 10-Q 809334
2 EX-31.1 a17-20600_1ex31d1.htm EX-31.1 10432
3 EX-31.2 a17-20600_1ex31d2.htm EX-31.2 10496
4 EX-32.1 a17-20600_1ex32d1.htm EX-32.1 6090
5 EX-32.2 a17-20600_1ex32d2.htm EX-32.2 6178
  Complete submission text file 0001104659-17-067204.txt   5074071

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20170930.xml EX-101.INS 1001358
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20170930.xsd EX-101.SCH 66624
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20170930_cal.xml EX-101.CAL 36331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20170930_def.xml EX-101.DEF 236978
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20170930_lab.xml EX-101.LAB 464768
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20170930_pre.xml EX-101.PRE 410976
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 171188455
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1